Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden

被引:58
作者
Kristinsson, Sigurdur Yngvi [1 ]
Derolf, Asa Rangert
Edgren, Gustaf
Dickman, Paul W.
Bjoerkholm, Magnus
机构
[1] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, SE-17176 Stockholm, Sweden
关键词
REMISSION INDUCTION; CANCER SURVIVAL; THERAPY; MORTALITY; DIAGNOSIS; STAGE; TRANSPLANTATION; MALIGNANCIES; ETHNICITY; DISTANCE;
D O I
10.1200/JCO.2008.18.2006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose An association between socioeconomic status (SES) and survival in acute myeloid leukemia (AML) and multiple myeloma (MM) has not been established in developed countries. We assessed the impact of SES on survival in two large population-based cohorts of AML and MM patients diagnosed in Sweden 1973 to 2005. Patients and Methods The relative risk of death (all cause and cause specific) in relation to SES was estimated using Cox's proportional hazards regression. We also conducted analyses stratified by calendar periods (1973 to 1979, 1980 to 1989, 1990 to 1999, and 2000 to 2005). Results We identified a total of 9,165 and 14,744 patients with AML and MM, respectively. Overall, higher white-collar workers had a lower mortality than other SES groups for both AML (P = .005) and MM (P < .005). In AML patients, a consistently higher overall mortality was observed in blue-collar workers compared with higher white-collar workers in the last three periods (hazard ratio [HR], 1.26; 95% CI, 1.05 to 1.51; HR, 1.23; 95% CI, 1.05 to 1.45; HR, 1.28; 95% CI, 1.04 to 1.57, respectively). In MM, no difference was observed in the first two calendar periods. However, in 1990 to 1999, self-employed (HR, 1.18; 95% CI, 1.02 to 1.37), blue-collar workers (HR, 1.18; 95% CI, 1.04 to 1.32), and retired (HR, 1.45; 95% CI, 1.16 to 1.80) had a higher mortality compared to higher white- collar workers. In 2000 to 2005, blue-collar workers had a higher mortality (HR, 1.31; 95% CI, 1.07 to 1.60) compared with higher white- collar workers. Conclusion SES was significantly associated with survival in both AML and MM. Most conspicuously, a lower mortality was observed among the highest SES group during more recent calendar periods. Differences in management, comorbidity, and lifestyle, are likely factors to explain these findings. J Clin Oncol 27: 2073-2080. (C) 2009 by American Society of Clinical Oncology
引用
收藏
页码:2073 / 2080
页数:8
相关论文
共 44 条
[1]  
Abou-Jawde RM, 2006, HAEMATOLOGICA, V91, P1410
[2]   Ethnicity and prognosis in acute myeloid leukemia [J].
Alcalai, R ;
Ben-Yehuda, D ;
Ronen, I ;
Paltiel, O .
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (02) :127-134
[3]   Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party [J].
Augustson, BM ;
Begum, G ;
Dunn, JA ;
Barth, NJ ;
Davies, F ;
Morgan, G ;
Behrens, J ;
Smith, A ;
Child, JA ;
Drayson, MT .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9219-9226
[4]  
AUVINEN A, 1977, IARC SCI PUBL, P377
[5]   Myeloma and race: A review of the literature [J].
Benjamin, M ;
Reddy, S ;
Brawley, OW .
CANCER AND METASTASIS REVIEWS, 2003, 22 (01) :87-93
[6]   Recent major improvement in long-term survival of younger patients with multiple myeloma [J].
Brenner, Hermann ;
Gondos, Adam ;
Pulte, Dianne .
BLOOD, 2008, 111 (05) :2521-2526
[7]   Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].
Calle, EE ;
Rodriguez, C ;
Walker-Thurmond, K ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638
[8]   SOCIOECONOMIC-STATUS AND CANCER SURVIVAL [J].
CELLA, DF ;
ORAV, EJ ;
KORNBLITH, AB ;
HOLLAND, JC ;
SILBERFARB, PM ;
LEE, KW ;
COMIS, RL ;
PERRY, M ;
COOPER, R ;
MAURER, LH ;
HOTH, DF ;
PERLOFF, M ;
BLOOMFIELD, CD ;
MCINTYRE, OR ;
LEONE, L ;
LESNICK, G ;
NISSEN, N ;
GLICKSMAN, A ;
HENDERSON, E ;
BARCOS, M ;
CRICHLOW, R ;
FAULKNER, CS ;
EATON, W ;
NORTH, W ;
SCHEIN, PS ;
CHU, F ;
KING, G ;
CHAHINIAN, AP .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1500-1509
[9]  
*CTR EP, 2007, SOC CANC INC SWED 20
[10]  
Deonandan R, 2000, Chronic Dis Can, V21, P114